Skip to main content

William G. McGuinness

  • Of Counsel | Litigation

New York

T: +1.212.859.8026

William G. McGuinness is of counsel to Fried Frank's Litigation Department, and served as chair of the Department from 2001-2015.  He is an elected Fellow of the American College of Trial Lawyers.

William primarily represents brokerage, securities and financial services industry clients in a broad range of complex securities and commercial litigation, including cases involving securities class actions, mergers and acquisitions and intellectual property.  He regularly represents issuers and underwriters in shareholder federal securities litigation.  He is also active in the M&A field.

William speaks regularly on topics concerning complex litigation, such as the impact of Daubert and other evidentiary and trial practice issues, and the Private Securities Litigation Reform Act.  He has spoken internationally on the extraterritorial application of the US securities law and is co-author of the chapter on "Mergers & Acquisitions" in the multi-volume treatise, Business and Commercial Litigation in Federal Courts.

William is consistently recognized by Chambers USA: America's Leading Lawyers for Business as a leading individual in Litigation: General Commercial. He is also consistently recognized by Legal 500 in Securities: Shareholder Litigation and Financial Services Litigation. He is consistently recognized by Benchmark: Litigation as a National Star and a New York Litigation Star.

William has been named by the National Association of Corporate Directors to the “NACD 100 Most Influential People in Corporate Governance and in the Boardroom.

Work highlights:

  • Represented the Audit Committee of the Board of JP Morgan Chase in connection with shareholder derivative litigation brought in connection with allegations of wrongdoing against JP Morgan Chase concerning LIBOR manipulation.  The case was dismissed on motion.
  • Represented JP Morgan Chase in connection with shareholder derivative litigation against the Board arising out of alleged misconduct in the energy market.
  • Represented the Special Litigation Committee of the Board of Chiquita Brands in connection with shareholder derivative litigation arising out of allegations of improper payments to various entities in Colombia.
  • Represented an international pharmaceutical company in connection with shareholder derivative litigation claims arising out of allegations of failure to disclose known adverse effects of one of its “blockbuster” drugs. Successfully persuaded the plaintiffs to abandon the claim.
  • Represented Novelis, the publicly-traded international aluminum rolling and recycling company, in an action commenced in the United States District Court for the Southern District of Ohio against Anheuser-Busch in a dispute concerning the dramatic rise in world-wide aluminum pricing.
  • Represented Novelis in litigation in Atlanta, Georgia involving Coke, also concerning aluminum pricing.
  • Representing Humana, Inc. in connection with federal securities and shareholder derivative litigation arising out of reduction in earnings guidance.
  • Represented Citadel Investment Group, LLC and CIG Media, LLC (collectively, Citadel) in lawsuits brought in the Delaware Court of Chancery by holders of two series of preferred stock of ION Media Networks, Inc.  These preferred stockholders claimed that an exchange offer made to them as part of a larger effort to restructure ION Media’s ownership and capital structure, and de-leverage the company, is wrongfully coercive and improperly extracts value from the preferred stockholders for the benefit of Citadel and NBC Universal, Inc., which have led the restructuring effort.  The Court denied the plaintiffs' motion for a preliminary injunction that would have halted the exchange offer.  The Delaware Supreme Court refused the plaintiffs’ motion for leave to pursue an interlocutory appeal, and the exchange was successfully completed.
  • Represented numerous underwriting syndicates in securities fraud and class action litigation.
  • Represented a major NY law firm in litigation that resulted from the collapse of Enron Corporation in 2001.  The firm was sued in January 2004 for securities fraud in connection with its representation of certain financial institutions that were engaging in complex structured finance transactions with Enron and special purpose entities commonly used in structured finance at the time.  The action was consolidated in the Southern District of Texas, and while discovery against the client was stayed under the Private Securities Litigation Reform Act of 1995 until its dismissal motion was decided, discovery by other parties proceeded, with more than 100 million pages of documents having been produced and dozens of depositions having been taken.  We moved to dismiss all claims in April 2004, and on December 5, 2005 the US District Court for the Southern District of Texas granted the motion and denied plaintiffs' request to replead.
  • Represented a special committee of the board of directors of a large multi-national pharmaceuticals company in connection with shareholder litigation arising out of the alleged marketing of certain drugs while supposedly in possession of non-public information regarding potential adverse health effects associated with those drugs.
  • Representing ONEOK, a leading natural gas company, in connection with shareholder class action litigation pending in Delaware Chancery Court arising out of a multi-billion dollar asset roll-up transaction. Our dismissal motion is pending.
  • Representing Dr. Patrick Soon-Shiong, President, Chief Executive Officer and controlling shareholder of American BioScience, Inc. in two lawsuits (one in Delaware Chancery Court and one in Illinois state court) alleging derivative and direct claims arising out of ABI's November 2005 merger into its subsidiary, Abraxis BioScience, Inc., formerly known as American Pharmaceutical Partners, Inc.
  • Representing a major insurance company in connection with various investigations arising out of practices in the insurance brokerage industry following allegations raised by the New York Attorney General.
  • Represented corporate entities owning the Palace Hotel in New York and the Hotel Bel-Air in Los Angeles in a dispute between the Sultan of Brunei and his brother, Prince Jefri, arising out of their disputed ownership of those hotels.  Through interpleader actions and a related action in Delaware, Mr. McGuinness was able to get a TRO and a stand-still agreement that have protected the corporate entities while the underlying dispute is litigated to a resolution in Brunei.
  • Represented Tracinda Corporation in its US$1b securities fraud lawsuit against DaimlerChrysler AG.

Professional associations

  • Chair of Committee on Attorney Client Relations, American College of Trial Lawyers
  • Member, Committee on the Federal Rules, Civil Procedure 23
  • Former Chair, Section on Litigation, Subcommittee on Complex Litigation, American Bar Association

News and insight

Back to top ↑